Search by Drug Name or NDC

    NDC 69238-1423-06 Methotrexate 2.5 mg/1 Details

    Methotrexate 2.5 mg/1

    Methotrexate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is METHOTREXATE SODIUM.

    Product Information

    NDC 69238-1423
    Product ID 69238-1423_efc08af1-49d5-4361-81ab-0d23e19d3f4c
    Associated GPIs 21300050100310
    GCN Sequence Number 036872
    GCN Sequence Number Description methotrexate sodium TABLET 2.5 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 38489
    HICL Sequence Number 003905
    HICL Sequence Number Description METHOTREXATE SODIUM
    Brand/Generic Generic
    Proprietary Name Methotrexate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methotrexate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name METHOTREXATE SODIUM
    Labeler Name Amneal Pharmaceuticals NY LLC
    Pharmaceutical Class Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210040
    Listing Certified Through 2024-12-31

    Package

    NDC 69238-1423-06 (69238142306)

    NDC Package Code 69238-1423-6
    Billing NDC 69238142306
    Package 36 TABLET in 1 BOTTLE (69238-1423-6)
    Marketing Start Date 2017-12-29
    NDC Exclude Flag N
    Pricing Information N/A